Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients
Félix Hernández
Rheumatology, 2014
View PDFchevron_right
Anti-TNF-α therapy for uveitis: Behçet and beyond
Philip Murray
Eye, 2005
View PDFchevron_right
Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
Virginia Villaverde
Rheumatology International, 2018
View PDFchevron_right
Anti-TNF Drugs for Chronic Uveitis in Adults—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Carlos Neves
Frontiers in Medicine, 2019
View PDFchevron_right
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Hande Celiker
BMC Ophthalmology
View PDFchevron_right
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab
Mauro Galeazzi
Clinical rheumatology, 2018
View PDFchevron_right
Anti-TNF- therapy for sight threatening uveitis
Seerp Baarsma
British Journal of Ophthalmology, 2005
View PDFchevron_right
Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
Mauro Galeazzi
Clinical Rheumatology, 2016
View PDFchevron_right
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review
Giuseppe Lopalco
Rheumatology international, 2017
View PDFchevron_right
Anti-TNF-alpha therapy for sight threatening uveitis
Seerp Baarsma
British Journal of Ophthalmology a Peer Review Journal For Health Professionals and Researchers in Ophthalmology, 2005
View PDFchevron_right
Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease, National multicenter study of 177 cases
Ricardo Blanco
Arthritis & Rheumatology
View PDFchevron_right
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open-label trial
ahmet gül
Arthritis and Rheumatism, 2005
View PDFchevron_right
Infliximab in the treatment of posterior uveitis in Behçet's disease
robin dhote
La Presse Médicale, 2005
View PDFchevron_right
Pentoxifylline for the treatment of anterior uveitis in Behcet���s disease: possible alternative for TNF blockers
Simone Appenzeller
2011
View PDFchevron_right
Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease
Nicole Stuebiger
Arthritis & Rheumatism, 2010
View PDFchevron_right
Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2010) Anti-TNF Agents for Behçet´s disease: analysis of published data on 369 patients. Semin Arthritis Rheum [PMID:21168186]
Nicole Stuebiger
Graefe's Archive for Clinical and Experimental Ophthalmology, 2011
View PDFchevron_right
Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years
Farhad Shahram
International Journal of Rheumatic Diseases, 2013
View PDFchevron_right
Role of Immunomodulatory and Biological Therapy in the Treatment of Patients with Behcet's Uveitis -Cases from Clinical Practice
Filip Gucev
Journal of Morphological Sciences, 2022
View PDFchevron_right
Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease
Shigeaki Ohno
Archives of Ophthalmology, 2012
View PDFchevron_right
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study
G. Gini, Maurizio Benucci
Rheumatology, 2007
View PDFchevron_right
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis
Shigeaki Ohno
The Journal of rheumatology, 2004
View PDFchevron_right
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
David Diaz-Valle
Ophthalmology, 2018
View PDFchevron_right
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome
Irene Mattioli
Inflammopharmacology, 2020
View PDFchevron_right
Long-term Efficacy and Safety of Low-dose Interferon Alpha2a Therapy in Severe Uveitis Associated With Behçet Disease
Phuc Lehoang
American Journal of Ophthalmology, 2008
View PDFchevron_right
Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients
G. Gendron, Phuc Lehoang
British Journal of Ophthalmology, 2007
View PDFchevron_right
Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis
Jesus Maese
Seminars in Arthritis and Rheumatism, 2011
View PDFchevron_right